Chemotherapy-induced nausea and vomiting.

作者信息

Hesketh Paul J

机构信息

Caritas St. Elizabeth's Medical Center, Boston, MA 02135, USA.

出版信息

N Engl J Med. 2008 Jun 5;358(23):2482-94. doi: 10.1056/NEJMra0706547.

DOI:10.1056/NEJMra0706547

PMID:18525044

Abstract

摘要

相似文献

[1]

Chemotherapy-induced nausea and vomiting.

N Engl J Med. 2008-6-5

[2]

Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.

J Support Oncol. 2003

[3]

Update on the management of chemotherapy-related nausea and vomiting: an emphasis on the new class of agents--neurokinin-1 receptor antagonists.

Clin Adv Hematol Oncol. 2006-7

[4]

Neurokinin antagonism and chemotherapy-induced emesis.

Am J Gastroenterol. 1999-11

[5]

Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.

Clin Adv Hematol Oncol. 2004-5

[6]

Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy.

J Clin Oncol. 2003-11-15

[7]

Antiemetic drugs.

Medsurg Nurs. 2009

[8]

Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.

J Oncol Pharm Pract. 2010-12

[9]

[Prevention of nausea and vomiting. Aprepitant, the first therapeutic acting NK-1 receptor antagonist].

Pharm Unserer Zeit. 2007

[10]

Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting.

Expert Rev Anticancer Ther. 2012-2

引用本文的文献

[1]

Inhaling Peppermint Essential Oil as a Promising Complementary Therapy in the Treatment of Nausea and Vomiting.

J Clin Med. 2025-7-17

[2]

Refractory Nausea and Vomiting Due to Central Nervous System Injury: A Focused Review.

Life (Basel). 2025-6-27

[3]

Neurokinin-1 receptor antagonists in the current management of chemotherapy-induced nausea and vomiting.

Front Med. 2025-7-5

[4]

Mechanism and Predictive Role of NUB1 Protein in Oestrogen Receptor Pathway of FEC-Treated Breast Cancer Patients.

Biomedicines. 2025-5-27

[5]

Incidence and Risk Factors of Platinum-Based Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis.

Curr Oncol. 2025-5-31

[6]

Hypophagia and body weight loss by tirzepatide are accompanied by fewer GI adverse events compared to semaglutide in preclinical models.

Sci Adv. 2025-6-20

[7]

Omission of dexamethasone in prophylaxis for highly emetogenic chemotherapy in patients with breast cancer.

Einstein (Sao Paulo). 2025-5-12

[8]

Comprehensive gut microbiota and metabolomics combined with network pharmacology reveal the effects of acupuncture treatment for chemotherapy-induced nausea and vomiting.

Transl Gastroenterol Hepatol. 2025-4-14

[9]

The Pharmacological and Clinical Roles of Antiemetics: A Narrative Review.

Cureus. 2025-1-13

[10]

Efficacy and safety of ondansetron orally soluble pellicle for preventing moderate- to high-emetic risk chemotherapy-induced nausea and vomiting.

BMC Cancer. 2025-1-6

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Chemotherapy-induced nausea and vomiting.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献